title: Functional magnetic resonance imaging reveals similar brain activity changes in two different animal models of schizophrenia.
abstract: OBJECTIVE
  In schizophrenia research, most of the functional imaging studies have been performed in psychotic patients, but little is known about brain areas involved in the expression of psychotic-like symptoms in animal models. The objective of this study was to visualize and compare brain activity abnormalities in a neurodevelopmental and a pharmacological animal model of schizophrenia.
  
  
  METHODS
  Blood perfusion of specific brain areas, taken as indirect measure of brain activity, was investigated in adult rats following either neonatal ventral hippocampal lesion or acute administration of phencyclidine. Quantitative perfusion magnetic resonance imaging was performed on five frontal brain slices using the continuous arterial spin labeling technique. The mean perfusion was calculated in several brain structures, which were identified on anatomical images.
  
  
  RESULTS
  Lesioned animals exhibiting deficits in prepulse inhibition of the startle reflex showed a significant blood perfusion increase in the nucleus accumbens, basolateral amygdala, ventral pallidum, entorhinal-piriform cortex, orbital prefrontal cortex, and in the bed nucleus of the stria terminalis, and a decrease of perfusion in the temporal cortex. Similar effects were seen following acute phencyclidine administration in naïve animals.
  
  
  CONCLUSIONS
  Our data point out specific cortical and subcortical brain areas involved in the development of psychotic-like symptoms in two different animal models of schizophrenia. The observed brain activity abnormalities are reminiscent of classical neuroimaging findings described in schizophrenic patients.
authors.affiliation: CNS Research, F. Hoffmann-La Roche Ltd., PRBD-N, Bldg 72/129, 4070, Basel, Switzerland. celine.risterucci@roche.com
authors.forename: Céline
authors.initials: C
authors.lastname: Risterucci
authors.forename: Karine
authors.initials: K
authors.lastname: Jeanneau
authors.forename: Stephanie
authors.initials: S
authors.lastname: Schöppenthau
authors.forename: Thomas
authors.initials: T
authors.lastname: Bielser
authors.forename: Basil
authors.initials: B
authors.lastname: Künnecke
authors.forename: Markus
authors.initials: M
authors.lastname: von Kienlin
authors.forename: Jean-Luc
authors.initials: JL
authors.lastname: Moreau
mesh_terms: D000161:Acoustic Stimulation / Q000379:methods; D000704:Analysis of Variance; D000818:Animals; D000831:Animals, Newborn; D001921:Brain / Q000098:blood supply / Q000503:physiopathology; D001931:Brain Mapping; D004195:Disease Models, Animal; D004307:Dose-Response Relationship, Radiation; D007091:Image Processing, Computer-Assisted / Q000379:methods; D007266:Inhibition, Psychological; D008279:Magnetic Resonance Imaging; D008297:Male; D008959:Models, Neurological; D010100:Oxygen / Q000097:blood; D010622:Phencyclidine; D051381:Rats; D017207:Rats, Sprague-Dawley; D017208:Rats, Wistar; D013216:Reflex, Startle / Q000502:physiology; D012559:Schizophrenia / Q000139:chemically induced / Q000378:metabolism / Q000503:physiopathology
chemical_list: D010622:Phencyclidine; D010100:Oxygen
references.citation: J Magn Reson. 2011 Dec;213(2):533-41
references.pmid: 22152368
references.citation: Brain Res. 2000 Mar 31;860(1-2):77-86
references.pmid: 10727625
references.citation: Eur Neuropsychopharmacol. 2001 Feb;11(1):51-9
references.pmid: 11226812
references.citation: Schizophr Res. 1999 May 4;37(1):35-44
references.pmid: 10227106
references.citation: Rev Neurosci. 1999;10(1):59-90
references.pmid: 10356992
references.citation: Neuropsychopharmacology. 2000 Sep;23(3):223-39
references.pmid: 10942847
references.citation: Nat Rev Neurosci. 2002 Feb;3(2):142-51
references.pmid: 11836522
references.citation: Biol Psychiatry. 2000 Jul 15;48(2):99-109
references.pmid: 10903406
references.citation: Pharmacopsychiatry. 2003 Nov;36 Suppl 3:S152-7
references.pmid: 14677072
references.citation: Magn Reson Med. 1999 Jul;42(1):206-9
references.pmid: 10398969
references.citation: J Magn Reson Imaging. 2001 Apr;13(4):496-520
references.pmid: 11276094
references.citation: Magn Reson Med. 1995 Feb;33(2):209-14
references.pmid: 7707911
references.citation: Neuropsychopharmacology. 1993 Aug;9(1):67-75
references.pmid: 8397725
references.citation: NMR Biomed. 2003 Dec;16(8):459-67
references.pmid: 14696002
references.citation: Ann Neurol. 2000 Oct;48(4):556-66
references.pmid: 11026439
references.citation: Brain Res Brain Res Rev. 2000 Mar;31(2-3):138-46
references.pmid: 10719142
references.citation: Arch Gen Psychiatry. 1999 Jan;56(1):21-7
references.pmid: 9892252
references.citation: Neuroscience. 1999 Mar;90(3):823-32
references.pmid: 10218783
references.citation: Arch Gen Psychiatry. 1994 Mar;51(3):199-214
references.pmid: 8122957
references.citation: Trends Pharmacol Sci. 2000 Aug;21(8):314-8
references.pmid: 10918638
references.citation: Schizophr Res. 2001 Apr 15;49(1-2):1-52
references.pmid: 11343862
references.citation: Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11650-5
references.pmid: 11573002
references.citation: Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):212-6
references.pmid: 1729691
references.citation: Cereb Cortex. 1997 Dec;7(8):740-8
references.pmid: 9408038
references.citation: Magn Reson Med. 2002 Aug;48(2):242-54
references.pmid: 12210932
references.citation: Cereb Cortex. 2002 Sep;12(9):983-90
references.pmid: 12183397
references.citation: Am J Psychiatry. 2000 Dec;157(12):2040-2
references.pmid: 11097974
references.citation: Ann N Y Acad Sci. 2000 Jun;911:1-24
references.pmid: 10911864
references.citation: Philos Trans R Soc Lond B Biol Sci. 1999 Jul 29;354(1387):1155-63
references.pmid: 10466143
references.citation: Proc Natl Acad Sci U S A. 1990 Dec;87(24):9868-72
references.pmid: 2124706
references.citation: Lancet. 1997 Jun 14;349(9067):1730-4
references.pmid: 9193383
references.citation: Schizophr Res. 2004 Feb 1;66(2-3):89-96
references.pmid: 15061240
references.citation: J Neurosci. 1996 Feb 1;16(3):877-85
references.pmid: 8558256
references.citation: Cereb Cortex. 2002 Sep;12(9):975-82
references.pmid: 12183396
references.citation: Brain. 1999 Apr;122 ( Pt 4):593-624
references.pmid: 10219775
references.citation: Int J Neuropsychopharmacol. 2001 Dec;4(4):385-91
references.pmid: 11806864
references.citation: Trends Neurosci. 1994 Feb;17(2):52-7
references.pmid: 7512768
references.citation: Nat Neurosci. 2002 Mar;5(3):267-71
references.pmid: 11865311
references.citation: Psychopharmacol Bull. 2002 Winter;36(1):102-29
references.pmid: 12397851
references.citation: Psychopharmacology (Berl). 1995 Nov;122(1):35-43
references.pmid: 8711062
references.citation: Arch Gen Psychiatry. 1986 Feb;43(2):114-24
references.pmid: 3947207
references.citation: Neurosci Res. 2002 Jun;43(2):93-110
references.pmid: 12067745
references.citation: Fortschr Neurol Psychiatr. 2003 Feb;71(2):72-83
references.pmid: 12579470
references.citation: J Neural Transm (Vienna). 1999;106(2):183-96
references.pmid: 10226938
references.citation: Am J Psychiatry. 1997 Dec;154(12):1676-82
references.pmid: 9396945
references.citation: Synapse. 1995 Jun;20(2):125-30
references.pmid: 7570341
references.citation: Arch Gen Psychiatry. 2001 Mar;58(3):280-8
references.pmid: 11231835
references.citation: Neuropsychopharmacology. 1996 Dec;15(6):587-94
references.pmid: 8946433
references.citation: Hippocampus. 2001;11(5):520-8
references.pmid: 11732705
references.citation: Acta Psychiatr Scand. 1999 Aug;100(2):85-95
references.pmid: 10480194
references.citation: Neuropsychopharmacology. 2004 Feb;29(2):300-7
references.pmid: 14560321
references.citation: Behav Pharmacol. 2000 Jun;11(3-4):257-68
references.pmid: 11103880
references.citation: Lancet. 1999 Apr 24;353(9162):1425-30
references.pmid: 10227239
references.citation: Neuropsychopharmacology. 1995 Aug;13(1):9-19
references.pmid: 8526975
references.citation: Ann N Y Acad Sci. 2000 Jun;911:293-304
references.pmid: 10911881
references.citation: J Neuroradiol. 1996 Jun;23(1):1-5
references.pmid: 8767912
references.citation: Psychopharmacology (Berl). 2002 Jun;161(4):434-41
references.pmid: 12073172
references.citation: Br Med Bull. 2003;65:3-20
references.pmid: 12697613
references.citation: J Cereb Blood Flow Metab. 1996 Nov;16(6):1236-49
references.pmid: 8898697
references.citation: JAMA. 2001 Jul 25;286(4):427-35
references.pmid: 11466121
references.citation: Aust N Z J Psychiatry. 1996 Apr;30(2):195-209
references.pmid: 8811262
references.citation: Behav Pharmacol. 2000 Jun;11(3-4):269-78
references.pmid: 11103881